#457: Exploring the MedTech Commercial Valley of Death with Ryan O'Mahoney
Ryan O'Mahoney, founder of Catalyst Ventures and former VP at Precision X-Ray and Stryker, explains the 'commercial valley of death' in MedTech, where startups fail after FDA clearance due to underestimating institutional purchasing complexity. He argues that founders must integrate commercial strategy months before regulatory approval to align clinical data with operational ROI for hospital administrators and value analysis committees. O'Mahoney compares traditional full-time hiring, independent consulting, and distribution models, advocating for modern fractional commercial teams to preserve capital while building necessary momentum. He emphasizes that successful adoption requires navigating the gap between clinician enthusiasm and administrative budget constraints through early, structured engagement.